The effect of Abduction therapy on stable developmental dysplasia of the hip (DDH) between the age of 3 and 6 months.

The effect of Abduction therapy on stable developmental dysplasia of the hip (DDH) between the age of 3 and 6 months. - Hip dysplasia and abduction treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36841

Enrollment

100

Registered

2008-07-29

Start date

2008-12-22

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DDH Hip dysplasia

Interventions

supervised neglect versus regular treatment with Pavlik harness

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: All children age 3 and 4 months with stable DDH (Graf IIb and IIc) who present at the different participating clinical centers.

Exclusion criteria

Exclusion criteria: Children not in age category 3-4 months, Graf type I, D, III and IV.

Design outcomes

Primary

Measure	Time frame
US measurements after 3 months of supervised neglect or 3 motnhs of regular Pavlik harness treatment.	—

Secondary

Measure	Time frame
Femoral head necrosis percentage in abduction treatment group (control group)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)